BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19762444)

  • 1. Cell surface expression of adhesins for fibronectin correlates with virulence in Sporothrix schenckii.
    Teixeira PAC; de Castro RA; Nascimento RC; Tronchin G; Pérez Torres A; Lazéra M; de Almeida SR; Bouchara JP; Loureiro Y Penha CV; Lopes-Bezerra LM
    Microbiology (Reading); 2009 Nov; 155(Pt 11):3730-3738. PubMed ID: 19762444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in cell morphometry, cell wall topography and gp70 expression correlate with the virulence of Sporothrix brasiliensis clinical isolates.
    Castro RA; Kubitschek-Barreira PH; Teixeira PA; Sanches GF; Teixeira MM; Quintella LP; Almeida SR; Costa RO; Camargo ZP; Felipe MS; de Souza W; Lopes-Bezerra LM
    PLoS One; 2013; 8(10):e75656. PubMed ID: 24116065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of virulence profile, protein secretion and immunogenicity of different Sporothrix schenckii sensu stricto isolates compared with S. globosa and S. brasiliensis species.
    Fernandes GF; dos Santos PO; Rodrigues AM; Sasaki AA; Burger E; de Camargo ZP
    Virulence; 2013 Apr; 4(3):241-9. PubMed ID: 23324498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic characteristics associated with virulence of clinical isolates from the Sporothrix complex.
    Almeida-Paes R; de Oliveira LC; Oliveira MM; Gutierrez-Galhardo MC; Nosanchuk JD; Zancopé-Oliveira RM
    Biomed Res Int; 2015; 2015():212308. PubMed ID: 25961005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-DOPA accessibility in culture medium increases melanin expression and virulence of Sporothrix schenckii yeast cells.
    Teixeira PA; De Castro RA; Ferreira FR; Cunha MM; Torres AP; Penha CV; Rozental S; Lopes-Bezerra LM
    Med Mycol; 2010 Aug; 48(5):687-95. PubMed ID: 20392149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What lies beyond genetic diversity in Sporothrix schenckii species complex?: New insights into virulence profiles, immunogenicity and protein secretion in S. schenckii sensu stricto isolates.
    Romeo O; Criseo G
    Virulence; 2013 Apr; 4(3):203-6. PubMed ID: 23334066
    [No Abstract]   [Full Text] [Related]  

  • 7. Adhesion of the human pathogen Sporothrix schenckii to several extracellular matrix proteins.
    Lima OC; Figueiredo CC; Pereira BA; Coelho MG; Morandi V; Lopes-Bezerra LM
    Braz J Med Biol Res; 1999 May; 32(5):651-7. PubMed ID: 10412578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring virulence and immunogenicity in the emerging pathogen Sporothrix brasiliensis.
    Della Terra PP; Rodrigues AM; Fernandes GF; Nishikaku AS; Burger E; de Camargo ZP
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005903. PubMed ID: 28854184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and some properties of a glycoprotein of 70 kDa (Gp70) from the cell wall of Sporothrix schenckii involved in fungal adherence to dermal extracellular matrix.
    Ruiz-Baca E; Toriello C; Perez-Torres A; Sabanero-Lopez M; Villagomez-Castro JC; Lopez-Romero E
    Med Mycol; 2009 Mar; 47(2):185-96. PubMed ID: 18608892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships among genotypes, virulence and clinical forms of Sporothrix schenckii infection.
    Kong X; Xiao T; Lin J; Wang Y; Chen HD
    Clin Microbiol Infect; 2006 Nov; 12(11):1077-81. PubMed ID: 17002606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in virulence of Sporothrix schenckii conidia related to culture conditions and cell-wall components.
    Fernandes KSS; Mathews HL; Bezerra LML
    J Med Microbiol; 1999 Feb; 48(2):195-203. PubMed ID: 9989648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic vaccine using a monoclonal antibody against a 70-kDa glycoprotein in mice infected with highly virulent Sporothrix schenckii and Sporothrix brasiliensis.
    de Almeida JR; Kaihami GH; Jannuzzi GP; de Almeida SR
    Med Mycol; 2015 Jan; 53(1):42-50. PubMed ID: 25533623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in virulence between isolates of feline Sporotrichosis.
    Nobre Mde O; Antunes Tde A; de Faria RO; Cleff MB; Fernandes CG; Muschner AC; Meireles MC; Ferreiro L
    Mycopathologia; 2005 Aug; 160(1):43-9. PubMed ID: 16160768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of fungal cell wall components in adhesion of Sporothrix schenckii to human fibronectin.
    Lima OC; Figueiredo CC; Previato JO; Mendonça-Previato L; Morandi V; Lopes Bezerra LM
    Infect Immun; 2001 Nov; 69(11):6874-80. PubMed ID: 11598061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants of Sporothrix schenckii with attenuated virulence for mice.
    de Lima RF; Schäffer GV; Borba Cde M
    Microbes Infect; 2003 Sep; 5(11):933-8. PubMed ID: 12941384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential induction of Th1-prone immunity by human dendritic cells activated with Sporothrix schenckii of cutaneous and visceral origins to determine their different virulence.
    Uenotsuchi T; Takeuchi S; Matsuda T; Urabe K; Koga T; Uchi H; Nakahara T; Fukagawa S; Kawasaki M; Kajiwara H; Yoshida S; Moroi Y; Furue M
    Int Immunol; 2006 Dec; 18(12):1637-46. PubMed ID: 17035348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of virulence of different Sporothrix schenckii clinical isolates using experimental murine model.
    Brito MM; Conceição-Silva F; Morgado FN; Raibolt PS; Schubach A; Schubach TP; Schäffer GM; Borba CM
    Med Mycol; 2007 Dec; 45(8):721-9. PubMed ID: 17885952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a mouse model to evaluate clinical and environmental isolates of Sporothrix spp. from the largest U.S. epidemic of sporotrichosis.
    Dixon DM; Duncan RA; Hurd NJ
    J Clin Microbiol; 1992 Apr; 30(4):951-4. PubMed ID: 1572983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different virulence levels of the species of Sporothrix in a murine model.
    Arrillaga-Moncrieff I; Capilla J; Mayayo E; Marimon R; Mariné M; Gené J; Cano J; Guarro J
    Clin Microbiol Infect; 2009 Jul; 15(7):651-5. PubMed ID: 19624508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cell wall protein-based vaccine candidate induce protective immune response against Sporothrix schenckii infection.
    Portuondo DL; Batista-Duharte A; Ferreira LS; Martínez DT; Polesi MC; Duarte RA; de Paula E Silva AC; Marcos CM; Almeida AM; Carlos IZ
    Immunobiology; 2016 Feb; 221(2):300-9. PubMed ID: 26547105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.